![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhoFaDe5m9HpWVVnEhbl4r5wVKuKUJ0iHJaUJR1Ck8iCuxOw3FNqID5LcOlXmQId3oP8bdxZzWXRABktdtnDD4H9myEMouYRO3EEzE2rV5YYKiilp9-DZwZ17vWwxusmTrOCrUMazXRS18W/s320/mw-mast-tag2.gif)
![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj3odW4U8FvEGrdemCWKC1lTkcpzIp_TjoGQapAG2G8n0I7XG7jq0yyAuRQtkVnSHCOY-yBkCRO7LMkMmOps0dpYBAl7gPh5iMVbiamciguyktYego7lcH3CfF6twPG0wF4NRkUEfzrlZN3/s320/mw_logo_ani_160px.gif)
FDA and Novartis notified healthcare professionals of the introduction of a Myfortic Medication Guide to provide important safety information in language that patients can easily comprehend. By May 15, 2009, a copy of the Myfortic Medication Guide will be enclosed with every Myfortic bottle. Pharmacists are required to distribute a copy of the Medication Guide with every Myfortic prescription.
Read the MedWatch safety summary, including links to the Myfortic Dear Healthcare Professional letter, Prescribing Information, and Medication Guide, at:
http://www.fda.gov/medwatch/safety/2009/safety09.htm#CellCept
abrir aquí y acceder a los distintos documentos que informan de los respectivos "alertas":
FDA MedWatch - 2009 Safety Alerts for Human Medical Products
No hay comentarios:
Publicar un comentario